Study of Hemostasis in Patients With Congenital Disorder of Glycosylation

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

December 31, 2017

Conditions
Congenital Disorders of Glycosylation
Interventions
BIOLOGICAL

Coagulation assay

Conventional coagulation assays: prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, factor II, FV, FVII, FX, FVIII, FIX, FXI, FXII, d-dimers, antithrombin, protein C, protein S Thrombin generation assay: in presence or not of soluble thrombomodulin

OTHER

Clinical data collection

At inclusion, we recorded clinical data about the disease (type and form of congenital disorder of glycosylation, and antecedent of microvascular event: thrombosis, stroke-like or hemorrhages)

Trial Locations (1)

75015

Hôpital Necker Enfants malades, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03560570 - Study of Hemostasis in Patients With Congenital Disorder of Glycosylation | Biotech Hunter | Biotech Hunter